Please enable JavaScript to continue using this application.

Compare $NBP vs $NERV | Chartloom

Compare

$NBP vs $NERV

NovaBridge Biosciences · Minerva Neurosciences Inc

NBP

NovaBridge Biosciences

NERV

Minerva Neurosciences Inc

Compare $NBP vs $NERV

Comparing NovaBridge Biosciences and Minerva Neurosciences Inc

NBPNovaBridge Biosciences

NERVMinerva Neurosciences Inc

NBPNovaBridge Biosciences

Market cap

$161M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.3%

52W performance

-72.5%

FCF yield

-33.9%

NERVMinerva Neurosciences Inc

Market cap

$148M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-18.9%

52W performance

12.4%

FCF yield

-17.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NBP

NERV

Detailed metrics comparison

NBP

NovaBridge Biosciences

NERV

Minerva Neurosciences Inc

Market Cap

NBP$161M

NERV$148M

Enterprise Value

NBP$-30M

NERV$184M

Price

NBP$1.40

NERV$3.18

P/E Ratio

NBPN/A

NERVN/A

P/S Ratio

NBP3.29x

NERV0.00x

EV/Sales

NBP0.00x

NERV0.00x

EV/EBITDA

NBP0.00x

NERV28.95x

P/B Ratio

NBP0.77x

NERV19.58x

P/FCF Ratio

NBPN/A

NERVN/A

EV/FCF

NBP0.55x

NERV-7.01x

PEG Ratio

NBPN/A

NERVN/A

Forward P/E (NTM)

NBPN/A

NERVN/A

Forward P/S (NTM)

NBPN/A

NERVN/A

Revenue (TTM)

NBP$0

NERV$0

Revenue Growth (YoY)

NBPN/A

NERVN/A

Forward Rev Growth

NBP419.8%

NERV534.2%

Gross Margin (TTM)

NBP100.0%

NERV0.0%

Operating Margin (TTM)

NBP0.0%

NERV0.0%

EBITDA Margin (TTM)

NBP0.0%

NERV0.0%

Net Margin (TTM)

NBP0.0%

NERV0.0%

FCF Margin (TTM)

NBPN/A

NERVN/A

Net Income (TTM)

NBP$-43M

NERV$-395M

FCF (TTM)

NBP$-55M

NERV$-26M

EPS (TTM)

NBP$0.00

NERV-$5.00

ROE (TTM)

NBP-2091.0%

NERV-16962.0%

ROA (TTM)

NBP-1941.0%

NERV-50048.0%

ROIC (TTM)

NBP-2091.0%

NERV-16962.0%

Cash

NBP$191M

NERV$25M

Debt

NBP$0

NERV$60M

Net Cash/Debt

NBP$191M

NERV$-35M

Current Ratio (TTM)

NBP7.64x

NERV20.14x

Quick Ratio (TTM)

NBP7.60x

NERV19.04x

Debt/Equity (TTM)

NBP0.00x

NERV0.00x

Debt/Assets (TTM)

NBP0.0%

NERV0.0%

Interest Coverage (TTM)

NBPN/A

NERVN/A

Net Debt/EBITDA (TTM)

NBP0.00x

NERV0.00x

Beta

NBP1.69

NERV0.04

52W Performance

NBP-72.5%

NERV12.4%

YTD Performance

NBP-67.3%

NERV-18.9%

% from 52W High

NBP-79.5%

NERV-74.5%

% from 52W Low

NBP6.5%

NERV42.1%

Asset Turnover (TTM)

NBP0.11x

NERV0.00x

FCF Yield (TTM)

NBP-33.9%

NERV-17.7%

Earnings Yield (TTM)

NBP-26.8%

NERV-266.7%

Dividend Yield (TTM)

NBPN/A

NERVN/A

Rule of 40

NBP0.0

NERV0.0

EV/GP/RG

NBPN/A

NERVN/A

Ticker research

View NBP research View NERV research

Metric	NBP NovaBridge Biosciences	NERV Minerva Neurosciences Inc
Market & Valuation
Market Cap	$161M	$148M
Enterprise Value	$-30M	$184M
Price	$1.40	$3.18
P/E Ratio	N/A	N/A
P/S Ratio	3.29x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	28.95x
P/B Ratio	0.77x	19.58x
P/FCF Ratio	N/A	N/A
EV/FCF	0.55x	-7.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	419.8%	534.2%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-43M	$-395M
FCF (TTM)	$-55M	$-26M
EPS (TTM)	$0.00	-$5.00
ROE (TTM)	-2091.0%	-16962.0%
ROA (TTM)	-1941.0%	-50048.0%
ROIC (TTM)	-2091.0%	-16962.0%
Financial Health
Cash	$191M	$25M
Debt	$0	$60M
Net Cash/Debt	$191M	$-35M
Current Ratio (TTM)	7.64x	20.14x
Quick Ratio (TTM)	7.60x	19.04x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	0.04
52W Performance	-72.5%	12.4%
YTD Performance	-67.3%	-18.9%
% from 52W High	-79.5%	-74.5%
% from 52W Low	6.5%	42.1%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-33.9%	-17.7%
Earnings Yield (TTM)	-26.8%	-266.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NBP research	View NERV research

Valuation

P/S Ratio

NERV

0.00x

NBP

3.29x

EV/FCF

NERV

-7.01x

NBP

0.55x

Growth & revenue

Forward Revenue Growth

NERV

534.2%

NBP

419.8%

Profitability & performance

Gross Margin

NBP

100.0%

NERV

0.0%

ROE

NBP

-2091.0%

NERV

-16962.0%

FCF Yield %

NERV

-17.7%

NBP

-33.9%

52-Week Performance

NERV

12.4%

NBP

-72.5%

Detailed metrics comparison

NBP

NovaBridge Biosciences

NERV

Minerva Neurosciences Inc

Market Cap

NBP$161M

NERV$148M

Enterprise Value

NBP$-30M

NERV$184M

Price

NBP$1.40

NERV$3.18

P/E Ratio

NBPN/A

NERVN/A

P/S Ratio

NBP3.29x

NERV0.00x

EV/Sales

NBP0.00x

NERV0.00x

EV/EBITDA

NBP0.00x

NERV28.95x

P/B Ratio

NBP0.77x

NERV19.58x

P/FCF Ratio

NBPN/A

NERVN/A

EV/FCF

NBP0.55x

NERV-7.01x

PEG Ratio

NBPN/A

NERVN/A

Forward P/E (NTM)

NBPN/A

NERVN/A

Forward P/S (NTM)

NBPN/A

NERVN/A

Revenue (TTM)

NBP$0

NERV$0

Revenue Growth (YoY)

NBPN/A

NERVN/A

Forward Rev Growth

NBP419.8%

NERV534.2%

Gross Margin (TTM)

NBP100.0%

NERV0.0%

Operating Margin (TTM)

NBP0.0%

NERV0.0%

EBITDA Margin (TTM)

NBP0.0%

NERV0.0%

Net Margin (TTM)

NBP0.0%

NERV0.0%

FCF Margin (TTM)

NBPN/A

NERVN/A

Net Income (TTM)

NBP$-43M

NERV$-395M

FCF (TTM)

NBP$-55M

NERV$-26M

EPS (TTM)

NBP$0.00

NERV-$5.00

ROE (TTM)

NBP-2091.0%

NERV-16962.0%

ROA (TTM)

NBP-1941.0%

NERV-50048.0%

ROIC (TTM)

NBP-2091.0%

NERV-16962.0%

Cash

NBP$191M

NERV$25M

Debt

NBP$0

NERV$60M

Net Cash/Debt

NBP$191M

NERV$-35M

Current Ratio (TTM)

NBP7.64x

NERV20.14x

Quick Ratio (TTM)

NBP7.60x

NERV19.04x

Debt/Equity (TTM)

NBP0.00x

NERV0.00x

Debt/Assets (TTM)

NBP0.0%

NERV0.0%

Interest Coverage (TTM)

NBPN/A

NERVN/A

Net Debt/EBITDA (TTM)

NBP0.00x

NERV0.00x

Beta

NBP1.69

NERV0.04

52W Performance

NBP-72.5%

NERV12.4%

YTD Performance

NBP-67.3%

NERV-18.9%

% from 52W High

NBP-79.5%

NERV-74.5%

% from 52W Low

NBP6.5%

NERV42.1%

Asset Turnover (TTM)

NBP0.11x

NERV0.00x

FCF Yield (TTM)

NBP-33.9%

NERV-17.7%

Earnings Yield (TTM)

NBP-26.8%

NERV-266.7%

Dividend Yield (TTM)

NBPN/A

NERVN/A

Rule of 40

NBP0.0

NERV0.0

EV/GP/RG

NBPN/A

NERVN/A

Ticker research

View NBP research View NERV research

Metric	NBP NovaBridge Biosciences	NERV Minerva Neurosciences Inc
Market & Valuation
Market Cap	$161M	$148M
Enterprise Value	$-30M	$184M
Price	$1.40	$3.18
P/E Ratio	N/A	N/A
P/S Ratio	3.29x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	28.95x
P/B Ratio	0.77x	19.58x
P/FCF Ratio	N/A	N/A
EV/FCF	0.55x	-7.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	419.8%	534.2%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-43M	$-395M
FCF (TTM)	$-55M	$-26M
EPS (TTM)	$0.00	-$5.00
ROE (TTM)	-2091.0%	-16962.0%
ROA (TTM)	-1941.0%	-50048.0%
ROIC (TTM)	-2091.0%	-16962.0%
Financial Health
Cash	$191M	$25M
Debt	$0	$60M
Net Cash/Debt	$191M	$-35M
Current Ratio (TTM)	7.64x	20.14x
Quick Ratio (TTM)	7.60x	19.04x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	0.04
52W Performance	-72.5%	12.4%
YTD Performance	-67.3%	-18.9%
% from 52W High	-79.5%	-74.5%
% from 52W Low	6.5%	42.1%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-33.9%	-17.7%
Earnings Yield (TTM)	-26.8%	-266.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NBP research	View NERV research